Commure Scribe vs iCAD (DeepHealth)

Commure Scribe, part of the Commure Ambient AI platform, uses speech recognition and generative AI to automatically capture patient encounters and generate structured clinical notes. The solution supports multiple input types, including live conversations, recordings, images, and existing notes, converting them into EHR-ready documentation. Commure Scribe integrates with major healthcare systems and is designed to reduce time spent charting while lowering cognitive burden for clinicians. The platform supports specialty-specific workflows and maintains physician control through mandatory review and approval processes. Commure has expanded rapidly across hospitals and health systems as demand …

iCAD develops AI-powered breast health solutions that help radiologists improve the early detection of breast cancer. Its ProFound Breast Health Suite uses deep learning to analyze mammograms, assess breast density, and identify suspicious findings. The platform is designed to increase diagnostic accuracy, reduce reading times, and optimize radiology workflows. iCAD solutions integrate with existing PACS and imaging systems and are used by hospitals, imaging centers, and breast screening programs worldwide. In 2025, iCAD was acquired by DeepHealth, a RadNet subsidiary, expanding DeepHealth's portfolio of AI-driven imaging technologies while retaining the iCAD brand.